A Hybrid Satellite Symposium at TTS 2022
Sunday, 11 September 2022
Registration and Refreshments
16:00 – 16:30
Symposium and Panel Discussion
16:30 – 17:30
Buenos Aires Convention Center (CEC)
Hall C2
Av. Figueroa Alcorta 2099
Buenos Aires, Argentina
Also Available to Virtual Attendees via Online Simulcast
You must be registered for TTS 2022 to attend this symposium.
This program is developed and offered by RMEI Medical Education, LLC.
This is not an official program of TTS.
This satellite symposium will be conducted during TTS 2022.
FACULTY
Roslyn B. Mannon, MD (Chair)
Professor of Medicine, Division of Nephrology
Professor of Pathology and Microbiology
Vice Chair of Research, Department of Medicine
Associate Chief of Research, Division of Nephrology
University of Nebraska Medical Center
Omaha, United States
Prof. Georg Böhmig, MD
Associate Professor
Division of Nephrology and Dialysis
Department of Medicine III
Medical University of Vienna
Vienna, Austria
Prof. Michael Mengel, MD
Professor and Chair
Department of Laboratory Medicine and Pathology
University of Alberta
Edmonton, Canada
Join us for this in-person Clinical Forum® panel discussion, where Drs. Mannon, Böhmig, and Mengel discuss clinical pearls for chronic active antibody-mediated rejection (AMR) in renal transplantation. This series of interactive discussions on AMR will cover underlying causes, diagnosis, and emerging therapies. Do not miss this opportunity to engage with colleagues, sharpen your diagnostic skills in AMR, and learn new therapeutic strategies from the experts!
PROGRAM AGENDA
Roslyn B. Mannon, MD (Chair)
Pathophysiology of Chronic Active AMR in Kidney Transplantation
Roslyn B. Mannon, MD and Panel
Diagnosing Chronic Active AMR: The Banff Criteria
Prof. Michael Mengel, MD and Panel
Emerging Therapies for Chronic Active AMR
Prof. Georg Böhmig, MD and Panel
All Faculty
WHO SHOULD ATTEND?
Transplant clinicians who manage patients with AMR.
LEARNING OBJECTIVES FOR ATTENDEES
Upon completion of this activity, participants should be better able to:
- Examine the underlying pathophysiology of chronic active antibody-mediated rejection (AMR) in kidney transplantation
- Employ Banff diagnostic criteria for chronic active AMR in renal allograft recipients
- Examine the potential role of emerging therapeutic approaches in the management of chronic active AMR
PROVIDER STATEMENT
This activity is provided by RMEI Medical Education, LLC.
SUPPORTER STATEMENT
This activity is supported by an independent educational grant from CSL Behring LLC.
ACCREDITATION
In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Physician Continuing Medical Education
RMEI Medical Education, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Financial Relationships
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.
Americans WIth Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact RMEI prior to the live event at (866) 770-RMEI.
FEE INFORMATION
There is no fee for this educational activity.
FOLLOW RMEI
Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.